Skip to main content

Cycloset FDA Approval History

FDA Approved: Yes (First approved May 5, 2009)
Brand name: Cycloset
Generic name: bromocriptine mesylate
Dosage form: Tablets
Company: VeroScience and S2 Therapeutics, Inc.
Treatment for: Diabetes, Type 2

Cycloset (bromocriptine) is a first-in-class, central acting agent for the treatment of Type 2 Diabetes.

Development timeline for Cycloset

May  6, 2009Approval VeroScience Announces FDA Approval of Cycloset for Treatment of Type 2 Diabetes

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.